SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001544227-22-000006
Filing Date
2022-11-08
Accepted
2022-11-08 09:02:49
Documents
62
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tpst-20220930.htm   iXBRL 10-Q 1474576
2 EX-10.1 ex101-writtenagreementcons.htm EX-10.1 29294
3 EX-31.1 exhibit311211.htm EX-31.1 9654
4 EX-31.2 exhibit312211.htm EX-31.2 9581
5 EX-32.1 exhibit321211.htm EX-32.1 6930
  Complete submission text file 0001544227-22-000006.txt   5519463

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpst-20220930.xsd EX-101.SCH 36557
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpst-20220930_cal.xml EX-101.CAL 52560
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpst-20220930_def.xml EX-101.DEF 148545
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tpst-20220930_lab.xml EX-101.LAB 460070
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpst-20220930_pre.xml EX-101.PRE 289090
56 EXTRACTED XBRL INSTANCE DOCUMENT tpst-20220930_htm.xml XML 756605
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35890 | Film No.: 221367433
SIC: 2834 Pharmaceutical Preparations